Navigation Links
Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results
Date:3/3/2011

ion, statements regarding: the anticipated U.S. market opportunity for IV acetaminophen, our ability to achieve formulary and market acceptance for OFIRMEV, our strategy for building a long-term hospital pain franchise, the sufficiency of our capital resources to fund our operations, and our financial estimates or projections.  You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.  Our actual future results may differ materially from our current expectations due to the risks and uncertainties inherent in our business.  These risks include our dependence on the successful commercialization of OFIRMEV; the risk that delays in achieving formulary acceptance for OFIRMEV at a substantial number of targeted accounts would enable competitors to further entrench their products and decrease the market potential for OFIRMEV; our ability to ensure an adequate and continued supply of OFIRMEV to meet anticipated market demand; the fact that OFIRMEV remains subject to substantial ongoing regulatory requirements; our ability to successfully enforce our intellectual property rights and defend our patents; the potential that we may be required to file a lawsuit to defend our patent rights or regulatory exclusivities from challenges by companies seeking to market generic versions of intravenous acetaminophen; the risk that we may not be able to raise sufficient capital when needed; and other risks detailed under "Risk Factors" and elsewhere in our periodic reports and our other filings made with the Securities and Exchange Commission from time to time. All forward-looking statements are qualified in their entirety by this cautionary statement, which is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995, and we undertake no obligation to revise or update this press release to reflect events or circumstances after the date hereof.

Cadence&
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the Cowen and Company 31st Annual Health Care Conference in Boston on March 9, 2011
2. Cadence Pharmaceuticals to Present at Two Investment Conferences in February 2011
3. AccessClosure Announces Launch of New Mynx Cadence™ Vascular Closure Device
4. Cadence Pharmaceuticals Announces Pricing of Public Offering of Common Stock
5. Cadence Pharmaceuticals Reports Third Quarter 2010 Financial Results
6. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2010 Financial Results on November 5, 2010
7. Cadence Pharmaceuticals to Present at Four Investment Conferences During the Month of September 2010
8. Oxford Finance Corporation Leads $30 Million Secured Loan Facility for Cadence Pharmaceuticals
9. Cadence Pharmaceuticals Announces FDA Extends New Drug Application Review for Intravenous Acetaminophen by Three Months
10. Cadence Pharmaceuticals CEO Ted Schroeder To Present at the Oppenheimer 20th Annual Healthcare Conference in New York City on November 4, 2009
11. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the BIOCOM Investor Conference in San Diego on October 27, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015 Research and Markets ... the "Urinary Catheters Market (Indwelling or Foley Catheters, ... Global Industry Analysis, Size, Share, Growth, Trends and Forecast ... , At present, the global market for ...
(Date:1/23/2015)... a third of reproductive-aged women enrolled in Medicaid, and more ... prescription for an opioid pain medication each year during 2008-2012, ... Weekly Report (MMWR). Opioids are typically prescribed ... They are also found in some prescription cough medications. The ...
(Date:1/23/2015)... MERIDIAN, Idaho , Jan. 23, 2015  Now available ... Patent No. 7,849,611) support that prevents ankle sprains by ... a brace, it fits securely around the outside of ... ankle mobility & comfort while still offering protection against ...
Breaking Medicine Technology:Urinary Catheters Market (Indwelling or Foley Catheters, Intermittent Catheters and Male External or Condom Catheters) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Urinary Catheters Market (Indwelling or Foley Catheters, Intermittent Catheters and Male External or Condom Catheters) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2
... PARK, N.C., April 25, 2011 GlaxoSmithKline (GSK) announced ... has approved Lamictal® XR™ (lamotrigine) Extended-Release Tablets ... older with partial seizures taking one anti-epileptic drug. This ... XR which is already approved as add-on treatment ...
... eye doctors , Rockland Eye Physicians and Surgeons, one of ... use of Alcon,s cutting edge AcrySof IQ ReSTOR IOL available ... other cataract treatments in that it allows the ... the use of bifocals or trifocals in many situations. ...
Cached Medicine Technology:FDA Approves Lamictal®XR™ (Lamotrigine) for Conversion to Monotherapy for Treatment of Partial Seizures in Appropriate Patients 2FDA Approves Lamictal®XR™ (Lamotrigine) for Conversion to Monotherapy for Treatment of Partial Seizures in Appropriate Patients 3FDA Approves Lamictal®XR™ (Lamotrigine) for Conversion to Monotherapy for Treatment of Partial Seizures in Appropriate Patients 4FDA Approves Lamictal®XR™ (Lamotrigine) for Conversion to Monotherapy for Treatment of Partial Seizures in Appropriate Patients 5Renowned New York Ophthalmologists, Drs. Glen Weiss and Robert Chen of Rockland Eye Physicians Use the AcrySof IQ ReSTOR IOL to Correct Cataracts Without Glasses 2Renowned New York Ophthalmologists, Drs. Glen Weiss and Robert Chen of Rockland Eye Physicians Use the AcrySof IQ ReSTOR IOL to Correct Cataracts Without Glasses 3
(Date:1/22/2015)... (PRWEB) January 23, 2015 AngelWeddingDress, the ... of 2015 maternity wedding dresses. View website ... are looking for maternity wedding dresses online for a ... gowns with high quality for them. Its maternity wedding ...
(Date:1/22/2015)... A new white paper by The Beryl ... the long-term care environment as well as provides recommendations ... paper, “The Power of Person-Centeredness in Long-Term Care: A ... the patient, resident and family experience in long-term care ...
(Date:1/22/2015)... January 22, 2015 For over 20 years, Dr. ... Oceanside and Vista area has treated just about every type ... injury circumstances. And for those same twenty-plus years, the team ... all those injuries with the best possible doctor. With ...
(Date:1/22/2015)... 22, 2015 A study recently ... flagship journal Medicine & Science in Sports & ... may help reduce gastrointestinal (GI) problems associated with ... Participants in the double-blind, placebo-controlled study took 10 ...
(Date:1/22/2015)... January 22, 2015 IsoComforter, Inc. has introduced ... with patented IsoTube design to treat specific body parts and ... most progressive and easy to use patented cold therapy machine ... sports related orthopedic and muscle injuries. IsoComforter has become ...
Breaking Medicine News(10 mins):Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2
... no survival difference for those with, without device , WEDNESDAY, ... first weeks after a heart attack does not improve survival, ... cardiac arrest occurred among those given the devices, which shock ... was about the same as for those who did not ...
... Researchers identify possible genetic links, but urge further study ... and genomic regions that might be associated with autism ... The researchers identified a single-letter change on chromosome 5 ... to help guide the growth of neurons and their ...
... Each year, an estimated 800,000 Americans will ... the victims survive, but their lives, and those of ... victims can suffer from a multitude of problems, including ... sleep disturbances. , Careforward , an organization ...
... (NYSE: CRDA ; CRDB) European third party administration ... of Broadspire, a Crawford company, continuing the leading TPA,s ... CRDA ; CRDB), the world,s largest independent provider of ... Broadspire brand at the Federation of European Risk Management ...
... VIEW, Calif., Oct. 7 Satellite Healthcare, one of ... services and a major sponsor of nephrology research, today ... 21st Annual San Francisco Author,s Luncheon. , The ... year more than 1,200 people are captivated by the ...
... 7 Coverall Health-Based Cleaning System(SM), a leading franchisor of ... as one of the "50 Top Franchises for Minorities" ... third year in a row. The list of top ... Today, the national daily newspaper. Coverall was also honored ...
Cached Medicine News:Health News:Early Defibrillator After Heart Attack May Not Pay Off 2Health News:Early Defibrillator After Heart Attack May Not Pay Off 3Health News:Potential Pieces of Autism Puzzle Revealed 2Health News:Mingling, Martinis & Mysterious Murder Masquerade at the Whitney to Benefit Carnival of Care 2Health News:Crawford & Company's Broadspire Unit Continues Its European Expansion 2Health News:Satellite Healthcare Partners With the National Kidney Foundation for the 21st Annual San Francisco Author's Luncheon 2Health News:Coverall Named Among '50 Top Franchises for Minorities' for Third Consecutive Year 2
ACE Control Serum provides the laboratory with vital information on the performance of the ACE chemistry assay....
Medical Claims Billing...
e-MDs Bill practice management system is used in the medical billing cycle....
BillingPro...
Medicine Products: